Improving the care and outcomes of residents of Canada living with metastatic NSCLC
Pfizer, Lung Health Foundation, Lung Cancer Canada, & The Quebec Lung Association
Pfizer, Lung Health Foundation (LHF), Lung Cancer Canada (LCC), and the Quebec Lung Association (QLA) are collaborating to offer a new grant opportunity seeking proposals for quality improvement initiatives focused on improving the care of outcomes of residents of Canada living with metastatic non-small cell lung cancer (NSCLC) with special focus on improving health equity in this setting.
Individual projects requesting up to $100,000 CAD will be considered. The estimated total available budget related to this RFP is $200,000 CAD.
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 19-Apr-2024 4:30 pm CST | 30-Apr-2024 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.